Literature DB >> 28582327

A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options.

Christina A Salazar1, Keith Isaacson, Stephanie Morris.   

Abstract

PURPOSE OF REVIEW: Intrauterine adhesions, also known as Asherman's syndrome, can have an impact on both reproductive outcomes and gynaecologic symptoms. Understanding the cause of intrauterine adhesions and the common clinical presentation will increase awareness of the condition and guide the patient to appropriate therapy. Surgical management offers favourable fertility outcomes and is often successful in restoring menstruation. RECENT
FINDINGS: Surgical management with hysteroscopic lysis of adhesions is the gold standard for treatment and adopting an office-based approach offers several advantages. Prevention of reformation of adhesions remains challenging and no single method for preventing recurrence has shown superiority. Cell-based therapies using endometrial stem/progenitor cells hold promise for future use in regenerating inadequate endometrium.
SUMMARY: Increased awareness of the symptoms suggestive of intrauterine adhesive disease, as well as recognition of common causes and preceding events, is crucial for early diagnosis, patient counselling and treatment. VIDEO ABSTRACT: http://links.lww.com/COOG/A36.

Entities:  

Mesh:

Year:  2017        PMID: 28582327     DOI: 10.1097/GCO.0000000000000378

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  37 in total

1.  Definition and Multiple Factors of Recurrent Spontaneous Abortion.

Authors:  Xiaolin La; Wenjuan Wang; Meng Zhang; Li Liang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Uterine Glands: Developmental Biology and Functional Roles in Pregnancy.

Authors:  Andrew M Kelleher; Francesco J DeMayo; Thomas E Spencer
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

3.  Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience.

Authors:  Lusine Aghajanova; Viji Sundaram; Chia-Ning Kao; Joseph M Letourneau; Evelyna Manvelyan; Marcelle I Cedars; Heather G Huddleston
Journal:  J Assist Reprod Genet       Date:  2021-10-06       Impact factor: 3.412

4.  Transplantation of bFGF-transfected bone mesenchymal stem cells on collagen scaffolds promotes the regeneration of injured rat endometrium.

Authors:  Fang Chen; Yingxin Gong; Ninghong Jiang; Jingjing Xiao; Yaping Wang; Limei Chen; Long Sui
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

5.  Hysteroscopic resection for management of early pregnancy loss: a case report and literature review.

Authors:  Stacy Young; Charles E Miller
Journal:  F S Rep       Date:  2022-03-10

6.  Expression and significance of estrogen receptor and progesterone receptor in endometrial tissue of patients with intrauterine adhesions.

Authors:  Jing Ge; Yiwen Chen; Hui Yang; Jingxue Zhao; Dongyan Ren; Xiaomei Wu
Journal:  Gland Surg       Date:  2021-04

7.  Management of Partial Hydatidiform Mole and Subsequent Intrauterine Adhesions: A Case Report and Literature Review.

Authors:  Dor Partosh; Genevieve Hale
Journal:  Innov Pharm       Date:  2020-10-28

Review 8.  Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration.

Authors:  X Li; H-F Lv; R Zhao; M-F Ying; A T Samuriwo; Y-Z Zhao
Journal:  Mater Today Bio       Date:  2021-02-25

9.  Patient-reported menstrual and obstetric outcomes following hysteroscopic adhesiolysis for Asherman syndrome.

Authors:  Blanca Morales; Peter Movilla; Joyce Wang; Jennifer Wang; Alexandria Williams; Tammy Chen; Himabindu Reddy; Jovana Tavcar; Megan Loring; Stephanie Morris; Keith Isaacson
Journal:  F S Rep       Date:  2021-01-11

Review 10.  Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases.

Authors:  Zhiqi Liao; Chang Liu; Lan Wang; Cong Sui; Hanwang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.